Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1750 of 3284 entries
View as:

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

Phase: N/A Priority: Normal
NCT ID: NCT04872621 Org: User:
Start: 06/30/21 End: 09/04/24 Due: 09/04/25

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol

Phase: N/A Priority: Normal
NCT ID: NCT01555099 Org: User:
Start: 04/30/12 End: 04/30/13 Due: 04/30/14

DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT03877224 Org: User:
Start: 04/04/19 End: 07/09/20 Due: 07/09/21

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02928354 Org: User:
Start: 11/25/16 End: 03/21/17 Due: 03/21/18

Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01335451 Org: User:
Start: 04/30/11 End: 10/31/11 Due: 10/31/12

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA)

Phase: N/A Priority: Normal
NCT ID: NCT03830866 Org: User:
Start: 02/15/19 End: 07/03/23 Due: 07/03/24

Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01078688 Org: User:
Start: 03/31/10 End: 10/31/10 Due: 10/31/11

A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06948747 Org: User:
Start: 05/06/25 End: 10/29/25 Due: 10/29/26

Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056

Phase: N/A Priority: Normal
NCT ID: NCT00700986 Org: User:
Start: 06/30/08 End: 08/31/08 Due: 08/31/09

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00329264 Org: User:
Start: 04/30/06 End: 08/31/07 Due: 08/31/08

Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00239343 Org: User:
Start: 10/31/04 End: 05/31/07 Due: 05/31/08

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

Phase: N/A Priority: Normal
NCT ID: NCT00542789 Org: User:
Start: 08/31/07 End: 02/28/09 Due: 02/28/10

A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT00238797 Org: User:
Start: 02/28/03 End: 03/31/06 Due: 03/31/07

Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01311622 Org: User:
Start: 03/31/11 End: 05/31/11 Due: 05/31/12

AMAZE™ Asthma Implementation QI Study

Phase: N/A Priority: Normal
NCT ID: NCT04901260 Org: User:
Start: 11/25/20 End: 06/30/21 Due: 06/30/22

Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered

Phase: N/A Priority: Normal
NCT ID: NCT01068743 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)

Phase: N/A Priority: Normal
NCT ID: NCT00108823 Org: User:
Start: 10/31/04 End: - Due: -

Antibiotic Therapy for Hospital-Acquired Infections in ICU Patients

Phase: N/A Priority: Normal
NCT ID: NCT00543894 Org: User:
Start: 02/28/06 End: - Due: -

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease

Phase: N/A Priority: Normal
NCT ID: NCT00928629 Org: User:
Start: 06/30/09 End: 10/31/09 Due: 10/31/10

An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT02208921 Org: User:
Start: 09/30/14 End: 05/31/15 Due: 05/31/16

Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325

Phase: N/A Priority: Normal
NCT ID: NCT00807937 Org: User:
Start: 12/31/08 End: 05/31/09 Due: 05/31/10

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02226822 Org: User:
Start: 09/20/14 End: 02/12/19 Due: 02/12/20

Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04675021 Org: User:
Start: 11/13/20 End: 01/11/21 Due: 01/11/22

AZD1222 Vaccine for the Prevention of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04540393 Org: User:
Start: 09/02/20 End: 05/11/22 Due: 05/11/23

A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)

Phase: N/A Priority: Normal
NCT ID: NCT03333018 Org: User:
Start: 07/06/15 End: 02/28/17 Due: 02/28/18